These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25075823)

  • 1. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001-2012).
    Boston SE; Lu X; Culp WT; Montinaro V; Romanelli G; Dudley RM; Liptak JM; Mestrinho LA; Buracco P
    J Am Vet Med Assoc; 2014 Aug; 245(4):401-7. PubMed ID: 25075823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
    Dank G; Rassnick KM; Sokolovsky Y; Garrett LD; Post GS; Kitchell BE; Sellon RK; Kleiter M; Northrup N; Segev G
    Vet Comp Oncol; 2014 Mar; 12(1):78-84. PubMed ID: 22737988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases (1998-2011).
    Tuohy JL; Selmic LE; Worley DR; Ehrhart NP; Withrow SJ
    J Am Vet Med Assoc; 2014 Dec; 245(11):1266-73. PubMed ID: 25406707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.
    Giacobino D; Camerino M; Riccardo F; Cavallo F; Tarone L; Martano M; Dentini A; Iussich S; Lardone E; Franci P; Valazza A; Manassero L; Del Magno S; De Maria R; Morello E; Buracco P
    Vet Comp Oncol; 2021 Dec; 19(4):651-660. PubMed ID: 33751759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma.
    Ottnod JM; Smedley RC; Walshaw R; Hauptman JG; Kiupel M; Obradovich JE
    Vet Comp Oncol; 2013 Sep; 11(3):219-29. PubMed ID: 23909996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases (2006-2012).
    Kawabe M; Mori T; Ito Y; Murakami M; Sakai H; Yanai T; Maruo K
    J Am Vet Med Assoc; 2015 Nov; 247(10):1146-53. PubMed ID: 26517618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of surgical excision and evaluation of factors associated with survival time in dogs with lingual neoplasia: 97 cases (1995-2008).
    Culp WT; Ehrhart N; Withrow SJ; Rebhun RB; Boston S; Buracco P; Reiter AM; Schallberger SP; Aldridge CF; Kent MS; Mayhew PD; Brown DC
    J Am Vet Med Assoc; 2013 May; 242(10):1392-7. PubMed ID: 23634684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional implant for treatment of primary oral malignant melanoma in dogs.
    Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA
    J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
    MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
    Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma.
    Treggiari E; Grant JP; North SM
    J Vet Med Sci; 2016 Jun; 78(5):845-50. PubMed ID: 26781703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.
    Grosenbaugh DA; Leard AT; Bergman PJ; Klein MK; Meleo K; Susaneck S; Hess PR; Jankowski MK; Jones PD; Leibman NF; Johnson MH; Kurzman ID; Wolchok JD
    Am J Vet Res; 2011 Dec; 72(12):1631-8. PubMed ID: 22126691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical excision of anal sac apocrine gland adenocarcinomas with and without adjunctive chemotherapy in dogs: 42 cases (2005-2011).
    Potanas CP; Padgett S; Gamblin RM
    J Am Vet Med Assoc; 2015 Apr; 246(8):877-84. PubMed ID: 25835172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK.
    Verganti S; Berlato D; Blackwood L; Amores-Fuster I; Polton GA; Elders R; Doyle R; Taylor A; Murphy S
    J Small Anim Pract; 2017 Jan; 58(1):10-16. PubMed ID: 28094857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study of survival time and prognostic factors for dogs with small intestinal adenocarcinoma treated by tumor excision with or without adjuvant chemotherapy.
    Smith AA; Frimberger AE; Moore AS
    J Am Vet Med Assoc; 2019 Jan; 254(2):243-250. PubMed ID: 30605388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of 42 dogs with scapular tumors treated by scapulectomy: a Veterinary Society of Surgical Oncology (VSSO) retrospective study (1995-2010).
    Montinaro V; Boston SE; Buracco P; Culp WT; Romanelli G; Straw R; Ryan S
    Vet Surg; 2013 Nov; 42(8):943-50. PubMed ID: 24433298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and prognostic factors following curative-intent surgery for oral tumours in dogs: 234 cases (2004 to 2014).
    Sarowitz BN; Davis GJ; Kim S
    J Small Anim Pract; 2017 Mar; 58(3):146-153. PubMed ID: 28224623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
    Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
    J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation.
    Théon AP; Rodriguez C; Madewell BR
    J Am Vet Med Assoc; 1997 Mar; 210(6):778-84. PubMed ID: 9074679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.